Gender influence on postprandial lipemia in heterozygotes for familial hypercholesterolemia

Annals of Clinical and Laboratory Science

Volumn 37, Issue 4, 2007, Pages 335-342

  Kolovou, Genovefa D ^a   Anagnostopoulou, Katherine K ^a   Damaskos, Dimitris S ^a   Mihas, Constantinos ^b   Mavrogeni, Sofia ^a   Hatzigeorgiou, George ^a   Theodoridis, Theodor ^c   Mikhailidis, Dimitri P ^d   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b General Hospital   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coronary heart disease; Familial hypercholesterolemia; Men vs women; Postprandial lipemia

Indexed keywords

FAT; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; DIET RESTRICTION; EVALUATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENDER; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID DIET; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 36148992930     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wiegman A, Rodenburg J, de Jongh S, Defesche JC, Bakker HD, Kastelein JJ, Sijbrands EJ. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children. Circulation 2003;107:1473-1478.
2. McLarty A, Mann N, Lawson WE, Foster A. Women's heart health series: a mini-symposium. Med Sci Monit 2003;9:103-110.
3. Gotto AM Jr. Triglyceride as a risk factor for coronary artery disease. Am J Cardiol 1998;82:22-25.
4. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000;86:943-949.
5. Dayspring TD. Coronary heart disease in women: triglycerides and lipoprotein biology. J Gend Specif Med 2002;5:27-33.
6. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-219.
7. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999;246:341-355.
8. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-485.
9. Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 2001;47:111-136.
10. Meyer E, Westerveld HT, de Ruyter-Meijstek FC, van Greevenbroek MM, Rienks R, van Rijn HJ, Erkelens DW, de Bruin TW. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis 1996;124:221-235.
11. Boquist S, Ruotolo G, Tang R, Bjorkegren J, Bond MG, de Faire U, Karpe F, Hamsten A. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999;100:723-728.
12. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iaina A. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996;312:936-939.
13. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003;168:1-14.
14. Kolovou GD, Anagnostopoulou KK, Pilaris ND, Giannopoulou M, Hoursalas IS, Pavlidis AN, Adamopoulou E, Valaora AI, Mikhailidis DP, Cokkinos DV. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia. J Womens Health 2004;13:1119-1126.
15. Kolovou GD, Anagnostopoulou KK, Pilatis ND, Iraklianou S, Hoursalas IS, Liberi S, Pavlidis AN, Dritsas A, Mikhailidis DP, Cokkinos DV. Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia. Int J Clin Pract 2005;59:311-317.
16. Kolovou GD, Daskalova D, Iraklianou SA, Adamopoulou EN, Pilatis ND, Hatzigeorgiou GC, Cokkinos DV. Postprandial lipemia in hypertension. J Am Coll Nutr 2003;22:80-87.
17. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-1345.
18. Kolovou G, Daskalova D, Anagnostopoulou K, Hoursalas I, Voudris V, Mikhailidis DP, Cokkinos DV. Postprandial hypertriglyceridaemia in patients with Tangier disease. J Clin Pathol 2003;56:937-941.
19. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem 2005;12:1931-1945.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Bergeron J, Gagne C, Couture P. Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation. J Lipid Res 2004;45:866-872.
22. Twisk J, Gillian-Daniel DL, Tebon A, Wang L, Barrett PH, Attie AD. The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest 2000;105:521-532.
23. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993;153:2209-2216.
24. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987;114:413-419.
25. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14.
26. Goldstein JL, Brown MS: Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. PNAS USA 1973;70:2804-2808.
27. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109(Suppl 1):2-7.
28. Cabezas MC, de Bruin TW, Westerveld HE, Meijer E, Erkelens DW. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. J Intern Med 1998;244:299-307.
29. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 1983;737:197-222.
30. Mamo JC, Smith D, Yu KC, Kawaguchi A, Harada-Shiba M, Yamamura T, Yamamoto A. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia. Eur J Clin Invest 1998;28:379-384.
31. Van Beek AP, De Ruijter-Heijstek FC, Erkelens DW, De Bruin TWA. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 1999;19:2737-2741.
32. Morrow PG, Marshall WP, Kim HJ, Kalkhoff RK. Metabolic response to starvation. II. Effects of sex steroid administration to pre- and postmenopausal women. Metabolism 1981;30:274-278.
33. Bonen A, Haynes FJ, Watson-Wright W, Sopper MM, Pierce GN, Low MP, Graham TE. Effects of menstrual cycle on metabolic responses to exercise. J Appl Physiol 1983;55:1506-1513.
34. Demacker PN, Mol MJ, Stalenhoef AF. Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol. Biochem J 1990;272:647-651.
35. Jensen MD, Martin ML, Cryer PE, Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 1994;266:914-920.
36. Westerveld HE. Estrogens and postprandial lipid metabolism. Atherosclerosis 1998;141(Suppl 1):105-107.
37. Heiling VJ, Jensen MD. Free fatty acid metabolism in the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab 1992;74:806-810.
38. Matthews KA, Abrams B, Crawford S, Miles T, Neer R, Powell LH, Wesley D. Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity. Int J Obes Relat Metab Disord 2001;25:863-873.